$Merrimack Pharmaceuticals, Inc.(MACK)$ 8-K - Current report Filed: 2017-10-10 AccNo: 0001193125-17-307131 Size: 147 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接